![](https://unicorn-nest.com/wp-content/uploads/2021/11/Thermo-Fisher-Scientific-scaled.jpg?x55332)
Related Funds
Fund Name | Location |
Brightbridge Ventures | England, London, United Kingdom |
Formula Ventures | Israel, Tel Aviv, Tel Aviv District |
Industrial Investment Corporation | - |
Jove Capital | - |
LAC | Japan, Tokyo |
MAS Holdings | Colombo, Sri Lanka, Western Province |
MVI Finance | - |
North River Ventures | New York, New York, United States |
Novozymes | Bagsværd, Denmark, Hovedstaden |
OVO | Indonesia, Jakarta, Jakarta Raya |
Pangaea Asset Management | Chicago, Illinois, United States |
QBE Ventures | Australia, New South Wales, Sydney |
SANTACO | Gauteng, Pretoria, South Africa |
Schroder Ventures | England, London, United Kingdom |
Tern | England, London, United Kingdom |
Thyme | - |
University of California, Berkeley | Berkeley, California, United States |
West Fund | Beijing, Beijing, China |
Yuanchi Touzi | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CytoReason | $80M | 17 Jul 2024 | Tel Aviv, Tel Aviv, Israel | ||
$150M | 23 Feb 2021 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CytoReason | $80M | 17 Jul 2024 | Tel Aviv, Tel Aviv, Israel | ||
$150M | 23 Feb 2021 | Shanghai, China |